Gemcitabine-releasing polymeric films for covered self-expandable metallic stent in treatment of gastrointestinal cancer

International Journal of Pharmaceutics

Volumn 427, Issue 2, 2012, Pages 276-283

  Lee, Jang Won ^a   Yang, Su Geun ^b,c   Na, Kun ^a  

^a The Catholic University of Korea   (South Korea)

^b Inha University School of Medicine   (South Korea)

^c Utah Inha DDS and Advanced Theapeutics Research Center   (South Korea)

Author keywords

Bile duct cancer; Gastrointestinal cancer; Gemcitabine; Nonvascular drug eluting covered stents; Stenosis

Indexed keywords

GEMCITABINE; INTERLEUKIN 12; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE P38; POLITEF; POLOXAMER; POLYETHERURETHAN; POLYURETHAN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILE DUCT CARCINOMA; CANCER INHIBITION; COLON CANCER; CONTROLLED STUDY; CYTOTOXICITY; DIGESTIVE SYSTEM CANCER; DRUG ELUTING STENT; DRUG RELEASE; HUMAN; HUMAN CELL; MATERIAL COATING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ALLOYS; ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; CELL COUNT; CELL PROLIFERATION; CELL SURVIVAL; COLONIC NEOPLASMS; CONSTRICTION, PATHOLOGIC; CYTOKINES; DEOXYCYTIDINE; DRUG-ELUTING STENTS; GASTROINTESTINAL NEOPLASMS; HUMANS; MEMBRANES, ARTIFICIAL; MICE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; POLOXAMER; POLYMERS; POLYTETRAFLUOROETHYLENE; POLYURETHANES;

EID: 84862811357     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2012.02.016     Document Type: Article

References (30)

1. B.C. Baguley, and G.J. Finlay Pharmacokinetic/cytokinetic principles in the chemotherapy of solid tumours Clin. Exp. Pharmacol. Physiol. 22 1995 825 828
2. M. Bezzi, A. Zolovkins, V. Cantisani, F. Salvatori, M. Rossi, F. Fanelli, and P. Rossi New ePTFE/FEP-covered stent in the palliative treatment of malignant biliary obstruction J. Vasc. Interv. Radiol. 13 2002 581 589
3. M. Burstow, T. Kelly, S. Panchani, I.M. Khan, D. Meek, B. Memon, and M.A. Memon Outcome of palliative esophageal stenting for malignant dysphagia: a retrospective analysis Dis. Esophagus 22 2009 519 525
4. J. Carmichael, U. Fink, R.C. Russell, M.F. Spittle, A.L. Harris, G. Spiessi, and J. Blatter Phase II study of gemcitabine in patients with advanced pancreatic cancer Br. J. Cancer 73 1996 101 105
5. J. Carmichael, K. Possinger, P. Phillip, M. Beykirch, H. Kerr, J. Walling, and A.L. Harris Advanced breast cancer: a phase II trial with gemcitabine J. Clin. Oncol. 13 1995 2731 2736
6. D.J. Cohen, J.A. Breall, K.K. Ho, R.E. Kuntz, L. Goldman, D.S. Baim, and M.C. Weinstein Evaluating the potential cost-effectiveness of stenting as a treatment for symptomatic single-vessel coronary disease. Use of a decision-analytic model Circulation 89 1994 1859 1874
7. R.J. Davies, I.B. D'Sa, M.E. Lucarotti, A.L. Fowler, A. Tottle, P. Birch, and T.A. Cook Bowel function following insertion of self-expanding metallic stents for palliation of colorectal cancer Colorectal Dis. 7 2005 251 253
8. M.P. Davis, and C. Nouneh Modern management of cancer-related intestinal obstruction Curr. Oncol. Rep. 2 2000 343 350
9. G. Dussaillant, F. Ayala, A. Ramirez, H. Ugalde, A.M. Silva, E. Farias, and M. Oyonarte Endovascular stent implantation in the treatment of coronary artery disease: angiographic, and immediate and late clinical results Rev. Med. Chil. 126 1998 1195 1205
10. T.A. Fischell Polymer coatings for stents. Can we judge a stent by its cover? Circulation 94 1996 1494 1495
11. E. Fruscella, D. Gallo, G. Ferrandina, G. D'Agostino, and G. Scambia Gemcitabine: current role and future options in the treatment of ovarian cancer Crit. Rev. Oncol. Hematol. 48 2003 81 88
12. G.L. Gallia, S. Brem, and H. Brem Local treatment of malignant brain tumors using implantable chemotherapeutic polymers J. Natl. Compr. Canc. Netw. 3 2005 721 728
13. T. Hoang, K. Kim, A. Jaslowski, P. Koch, P. Beatty, J. McGovern, M. Quisumbing, G. Shapiro, R. Witte, and J. Schiller Phase II study of second-line gemcitabine in sensitive or refractory small cell lung cancer Lung Cancer 42 2003 97 102
14. Y. Hui, and J. Reitz Gemcitabine: a cytidine analogue active against solid tumors Am. J. Health. Syst. Pharm. 54 1997 162
15. I. Isao, O. Takashi, K. Keiichi, and Y. Takashi Covered expandable metallic stents for malignant biliary obstructions. Comparison of covered versus bare stents Jpn. J. Clin. Radiol. 45 2000 323 328
16. H. Isayama, Y. Komatsu, T. Tsujino, N. Sasahira, K. Hirano, N. Toda, Y. Nakai, N. Yamamoto, M. Tada, H. Yoshida, Y. Shiratori, T. Kawabe, and M. Omata A prospective randomised study of covered versus uncovered diamond stents for the management of distal malignant biliary obstruction Gut 53 2004 729 734
17. K. Katsanos, T. Sabharwal, and A. Adam Stenting of the lower gastrointestinal tract: current status Cardiovasc. Intervent. Radiol. 34 2010 462 473
18. H.J. Kim, J.Y. Park, S. Bang, S.W. Park, Y.C. Lee, and S.Y. Song Self-expandable metal stents for recurrent malignant obstruction after gastric surgery Hepatogastroenterology 56 2009 914 917
19. T.G. Kim, H. Lee, Y. Jang, and T.G. Park Controlled release of paclitaxel from heparinized metal stent fabricated by layer-by-layer assembly of polylysine and hyaluronic acid-g-poly(lactic-co-glycolic acid) micelles encapsulating paclitaxel Biomacromolecules 10 2009 1532 1539
20. L. Machan Clinical experience and applications of drug-eluting stents in the noncoronary vasculature, bile duct and esophagus Adv. Drug Deliv. Rev. 58 2006 447 462
21. S. Moon, S.G. Yang, and K. Na An acetylated polysaccharide-PTFE membrane-covered stent for the delivery of gemcitabine for treatment of gastrointestinal cancer and related stenosis Biomaterials 32 2011 3603 3610
22. D. Paolino, D. Cosco, L. Racanicchi, E. Trapasso, C. Celia, M. Iannone, E. Puxeddu, G. Costante, S. Filetti, D. Russo, and M. Fresta Gemcitabine-loaded PEGylated unilamellar liposomes vs GEMZAR: biodistribution, pharmacokinetic features and in vivo antitumor activity J. Control. Release 144 2010 144 150
23. B. Pili, C. Bourgaux, F. Meneau, P. Couvreur, and M. Ollivon Interaction of an anticancer drug, gemcitabine, with phospholipid bilayers J. Therm. Anal. Calorim. 98 2009 19 28
24. C.E. Rube, F. Wilfert, D. Uthe, J. Konig, L. Liu, A. Schuck, N. Willich, K. Remberger, and C. Rube Increased expression of pro-inflammatory cytokines as a cause of lung toxicity after combined treatment with gemcitabine and thoracic irradiation Radiother. Oncol. 72 2004 231 241
25. Y. Shiino, Y. Inagaki, T. Okamoto, A. Miyakawa, M. Ono, T. Yokota, R. Ogawa, J. Nakamura, Y. Nakasato, and K. Onda Evaluation of local treatment for unresectable primary liver tumor Gan To Kagaku Ryoho 21 1994 2222 2224
26. D. Stupart Advances in the treatment of malignant large-bowel obstruction CME 25 2007 324 327
27. S. Thurnher, J. Lammer, M. Thurnher, F. Winkelbauer, O. Graf, and R. Wildling Covered self-expanding transhepatic biliary stents: clinical pilot study Cardiovasc. Intervent. Radiol. 19 1996 10 14
28. W.J. van der Giessen, A.M. Lincoff, R.S. Schwartz, H.M. van Beusekom, P.W. Serruys, D.R. Holmes Jr., S.G. Ellis, and E.J. Topol Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries Circulation 94 1996 1690 1697
29. F. Wang, G.M. Saidel, and J. Gao A mechanistic model of controlled drug release from polymer millirods: effects of excipients and complex binding J. Control. Release 119 2007 111 120
30. M. Zilberman, Y. Shifrovitch, M. Aviv, and M. Hershkovitz Structured drug-eluting bioresorbable films: microstructure and release profile J. Biomater. Appl. 23 2006 385 406